360 Stem Cell & Regenerative Medicine Newsletter - March 30, 2016

 weSRCH's Best of the Internet Award

360 Stem Cell & Regenerative Medicine Newsletter - Mar. 30, 2016

Featured video from RegMed Capital Conference:

Introduction to “Living Drugs” and the Curative Industries
Here’s an orbital view supplied by Gregory Bonfiglio (Proteus Venture Partners and COB CCRM); Jane Andrews, PhD (Frost & Sullivan) and Dr. Chris Mason (University College of London) at the 2015 World Stem Cell Summit & RegMed Capital Conference in Atlanta.

World Stem Cell Summit

World Stem Cell Summit & RegMed Capital Conference Returns to West Palm Beach
The international regenerative medicine community will convene for the 12th anniversary Summit in Florida, December 2016. Read media release.

THE “REGROW “Act- a new FDA regulatory pathway for cell therapies! Get the facts at www.celltherapynow.org

The San Diego Union-Tribune: J. Craig Venter Institute Unveils Bacterium with Smallest Functional Genome-Bare-bones Microbe Could be Engineered for Human Benefit
Time to prepare for synthetic life! Biotech reporter Bradley J. Fikes, solidly reports the results of Craig Venter’s latest “Future Shock” experiment. He writes, “Nearly six years after developing the first self-replicating life form with a chemically created genome, scientists at the J. Craig Venter Institute in La Jolla have cut that bacterium's genome nearly in half. The result is a creature with a smaller genome than has ever been found in nature. The bacterium's genome approximates the minimum amount necessary for life, providing a convenient vehicle for studying core life functions, according to a study published in the journal Science.” Read the U-T article.

The New York Family Office Meetings

The New Yorker (Annals of Science): The Stress Test-
Rivalries, intrigue, and fraud in the world of stem-cell research
Journalist Dana Goodyear has published in The New Yorker (Feb 29 the tragic and riveting saga on the STAP stem cell scandal. The stunning rise and fall of Haruko Obokata, the unfortunate role of Dr. Charles Vacanti, the suicide of Dr. Sasai and more. Goodyear accurately observes: “The promises of stem-cell research lie at the core of human desires—to understand our origins and to cheat death—and there is a great deal of money and prestige at stake. It is a ruthlessly competitive field, susceptible to fantasy and correspondingly sensitive to bunglers.” Read article.

AFP: Disgraced Celebrity Surgeon's Spoiled Dreams of Fame- Shoe Finally Drops on Macchiarini
“Dreams of fame and fortune turned into a nightmare for a once-renowned Italian surgeon who compared himself to Doctor Frankenstein and now stands accused of using patients as guinea pigs. Sweden's Karolinska Institute (KI), which awards the Nobel Prize for Medicine, fired Paolo Macchiarini this week after years of controversy.” Read article.


Motherboard: CRISPR Pioneer Feng Zhang Talks About What's Next for Gene Editing
CRISPR pioneer Zhang shares insights. “When asked about whether he has any concerns around the use of CRISPR—a technology that’s so efficient, and so accessible—Zhang didn’t seem overly worried, putting his faith in the scientific community.” Read article.


ABC News (Australia): Cross-species Organ Production Report Sparks Debate About Ethical Concerns of Stem Cell Science
ABC summarizes key findings of an expert report that raises ethical concerns about cross-species organ production, rogue stem cell clinics and fertility research- described as an “ethical minefield.” Read article.

The Independent: S ex will be Made Unnecessary by 'Designer Babies', Stanford Professor Says- The Scientific Developments Needed Are Not Far Off, Prof Greely Claims
Prof Greenly, Director at the Center for Law and the Biosciences, Stanford University, set out his case in his new book, The End of S ex and the Future of Human Reproduction. Read article.
360 editor’s comment: Any of you old enough remember the lyrics of the 1960’s dystopian ballad “In the Year 2525”?

In the year 6565
You won't need no husband, won't need no wife
You'll pick your son, pick your daughter too
From the bottom of a long glass tube

Read more: Zager And Evans - In The Year 2525 Lyrics | MetroLyrics

Lab Manager: Researchers Track Neural Stem Cells by Coloring Chicken Eggs from the Inside
“Findings allow scientists to study neural stem cells' behavior without harming them. An overwhelming number of researchers still struggle within the black hole of the effectiveness and safety of stem cell therapy for neurological diseases. While the complexity of understanding how neurons grow, connect, and function has long been studied, it remains a mystery, one that graduate student Forrest Goodfellow in the University of Georgia Regenerative Bioscience Center is helping unravel. Goodfellow, a graduate student in the University of Georgia's Regenerative Bioscience Center, has developed a unique approach of marrying stem cell biology and 3D imaging to track and label neural stem cells. His findings were published in the journal Advanced Functional Material.” Read article.


The Bahamas Weekly: Bahamas Government Signs MOU on Stem Cell Research with University of Miami
Prime Minister Christie said, “This is indeed a sentinel moment for my government because the University of Miami Leonard Miller School of Medicine is one of the leading Schools of Medicine in the United States of America and this now makes this outstanding institution available to us as we continue this sacred journey to ensure patient safety and enhance the quality and delivery of healthcare to our citizens throughout The Bahamas, to drive innovation in healthcare and to create new opportunities for Bahamians in the fields of Biotechnology, Cell Therapy and Regenerative Medicine." Read article.

360 editor’s note: DON’T MISS A THING! KEEP INFORMED on the latest developments relating to stem cells and translational medicine at the online Stem Cells Portal. The Portal is affiliated with the official journal of the Regenerative Medicine Foundation, Stem Cells Translational Medicine, published by AlphaMed Press.

360 Newsletter Editor

About GPI

The nonprofit Genetics Policy Institute and Regenerative Medicine Foundation seeks to establish a positive policy, regulatory and societal framework to enable research to flourish, under the highest ethical and medical standards. We seek to accelerate the discovery and development of lifesaving cures and therapies to alleviate human suffering due to chronic and terminal afflictions. Visit Website.

ConnectGPI on FacebookGPI on TwitterGPI on LinkedIn

World Stem Cell Summit & Regmed Capital Conference Overview

Copyright © 2016 Genetics Policy Institute, All rights reserved.

Domain: Medical
Category: Biology

Recent Newsletters

12 March, 2019
10 October, 2018
15 February, 2018